Fundraising FoxRxRevu
Denver, US · Founded 2013 · Delaware corporation · 2 known investors
Find your way into RxRevu
Sign up to find every way you can get introduced to RxRevu
- Your email: who you already know at RxRevu, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RxRevu team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Arrive Health provides technology that surfaces real-time, patient-specific clinical, cost, and coverage data inside electronic health record (EHR) and clinical workflows, helping providers and patients make more informed care decisions and understand true out-of-pocket costs. It serves healthcare providers, care teams, and patients across the U.S. healthcare value chain.
Founders & leadership
RxRevu was founded in 2013 by David Carmody Huntress.
Board
Investors · 2
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$38.5M disclosed across 5 of 7 rounds · 2014–2022
▶$6MraisedJan 2023 · 1 investors · Other Health CareRule 506(b)
- Stephen McHaleDirector
- Kyle KiserExecutive Officer, Director
- Andrew FirlikDirector
- Steve LindsethExecutive Officer, Director
- Christie CallahanExecutive Officer
- Toby CosgroveDirector
- Albert PrastDirector
- Benton BarneyExecutive Officer
- Richard ZaneDirector
- Aaron CornellExecutive Officer
- Daniel GallesDirector
- Lew ParkerExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedJul 2021 · 1 investors · Other Health CareRule 506(b)
- Stephen McHaleDirector
- Albert PrastDirector
- Andrew FirlikDirector
- Aaron CornellExecutive Officer
- Toby CosgroveDirector
- Kyle KiserExecutive Officer, Director
- Daniel GallesDirector
- Steve LindsethExecutive Officer, Director
- Richard ZaneDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedJan 2017 · 44 investors · Other Health CareRule 506(b)
- Kevin O'BrienExecutive Officer, Director
- Daniel CaronExecutive Officer
- Steve LindsethDirector
- David Carmody HuntressExecutive Officer, Director
- Jeffrey PattonDirector
- Offering amount
- $5.4M
- Amount sold
- $4.7M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.8MraisedOct 2016 · 44 investors · Other Health CareRule 506(b)
- Jeffrey PattonDirector
- David Carmody HuntressExecutive Officer, Director
- Kevin O'BrienExecutive Officer, Director
- Steve LindsethDirector
- Daniel CaronExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $3.8M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $149.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does RxRevu do?
- Arrive Health provides technology that surfaces real-time, patient-specific clinical, cost, and coverage data inside electronic health record (EHR) and clinical workflows, helping providers and patients make more informed care decisions and understand true out-of-pocket costs. It serves healthcare providers, care teams, and patients across the U.S. healthcare value chain.
- Who founded RxRevu?
- RxRevu was founded by David Carmody Huntress in 2013.
- Who are RxRevu's investors?
- RxRevu's investors include Nat Turner.
- How much funding has RxRevu raised?
- RxRevu has disclosed $38.5M raised across 5 of its 7 known rounds.
- Where is RxRevu headquartered?
- RxRevu is headquartered in Denver, US.